![Alexandra Balcom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 9 M $ au 31/05/2026
Alexandra Balcom is currently an Independent Director at Crescent Biopharma, Inc. since 2024 and Chief Financial Officer & Treasurer at Nuvalent, Inc. since 2021.
Former roles include Director at Crescent Biopharma, Inc. (Old), Controller at Agios Pharmaceuticals, Inc., and Vice President-Finance at SQZ Biotechnologies Co. from 2017 to 2021.
Education includes an MBA from Boston College and an undergraduate degree from the University of Massachusetts.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVALENT, INC. CLASS A 0,12 % | 01/06/2026 | 85 533 ( 0,12 % ) | 9 M $ | 31/05/2026 |
-.--% | 02/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NUVALENT, INC. | Directeur Financier/CFO | 01/01/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Corporate Officer/Principal | 01/03/2021 |
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
SQZ Biotechnologies Co.
 SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
